Anxiolytic and antidepressant effects of cannabidiol: a systematic review (original) (raw)

The therapeutic role of Cannabidiol in mental health: a systematic review

Rabia Khan

Journal of Cannabis Research, 2020

View PDFchevron_right

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

Amaya Austrich Olivares

Biomolecules, 2020

View PDFchevron_right

Strain, Sex, and Time Dependent Antidepressant-like Effects of Cannabidiol

Sâmia Joca

2021

View PDFchevron_right

Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview

paolo brambilla

Epidemiology and Psychiatric Sciences, 2018

View PDFchevron_right

Cannabidiol (CBD) use in psychiatric disorders: A systematic review

Stefania Bonaccorso

NeuroToxicology, 2019

View PDFchevron_right

Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels

Amanda Sales

Progress in neuro-psychopharmacology & biological psychiatry, 2018

View PDFchevron_right

UPDATES IN THE TREATMENT OF DEPRESSION WITH THE USE OF CANNABIS (Atena Editora)

Atena Editora

UPDATES IN THE TREATMENT OF DEPRESSION WITH THE USE OF CANNABIS (Atena Editora), 2024

View PDFchevron_right

A role for cannabidiol in psychiatry? Keep calm and follow the drug development rules

Gabriella Gobbi

The World Journal of Biological Psychiatry, 2019

View PDFchevron_right

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age

Alline Campos

Frontiers in Immunology, 2018

View PDFchevron_right

Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry

Gioacchino Calapai

Evidence-Based Complementary and Alternative Medicine

View PDFchevron_right

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5HT 1A receptors

Fabricio Moreira

British Journal of Pharmacology, 2010

View PDFchevron_right

Antidepressant-like effect of Δ 9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L

safwat ahmed

Pharmacology Biochemistry and Behavior, 2010

View PDFchevron_right

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

Felipe Gomes

Philosophical Transactions of the Royal Society B: Biological Sciences, 2012

View PDFchevron_right

Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex

Amanda Sales

Molecular neurobiology, 2018

View PDFchevron_right

Cannabidiol in Humans—The Quest for Therapeutic Targets

Stéphane Potvin

Pharmaceuticals, 2012

View PDFchevron_right

Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression

Melinda Urkon

Biomolecules

View PDFchevron_right

Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test

Fabricio Moreira

Progress in Neuro-psychopharmacology & Biological Psychiatry, 2006

View PDFchevron_right

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders

Amaya Austrich Olivares

Frontiers in Pharmacology, 2021

View PDFchevron_right

Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice

Karolina Sławińska

Pharmacology Biochemistry and Behavior, 2020

View PDFchevron_right

Prospects for the Use of Cannabinoids in Psychiatric Disorders

Tomasz Dzierżanowski

View PDFchevron_right

Evidences for the anti-panic actions of Cannabidiol

Alline Campos

Current Neuropharmacology, 2017

View PDFchevron_right

A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders

Jeffrey Witkin

Trends in Pharmacological Sciences, 2005

View PDFchevron_right

Novel Therapeutics in Mood Disorders (R Mansur, Section Editor) Medicinal Cannabis for the Treatment of Anxiety Disorders: a Narrative Review

Nial Wheate, Elise Schubert

Current Treatment Options in Psychiatry, 2022

View PDFchevron_right

Cannabidiol: an overview of some pharmacological aspects

Ruth Gallily

The Journal of Clinical Pharmacology, 2002

View PDFchevron_right

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research

Carlo Cifani

International Journal of Molecular Sciences

View PDFchevron_right

Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats

Natalya Kogan

International Journal of Molecular Sciences

View PDFchevron_right

Cannabinoid Use and Depression: Comparison of Natural and Synthetic Cannabinoids

serap akdeniz

Clinical Medical Reviews and Case Reports

View PDFchevron_right

Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice

Amaya Austrich Olivares

Pharmaceuticals

View PDFchevron_right